SelectQuote Inc. Reports Q4 FY2025 Revenue of $345.1M, Up from $307.2M; Swings to $12.9M Net Income from $31.0M Loss; Adjusted EBITDA Falls to $2.7M from $14.4M

Reuters
2025/08/21
SelectQuote Inc. Reports Q4 FY2025 Revenue of $345.1M, Up from $307.2M; Swings to $12.9M Net Income from $31.0M Loss; Adjusted EBITDA Falls to $2.7M from $14.4M

SelectQuote, Inc. (NYSE: SLQT) has released its financial results for the fourth quarter of fiscal year 2025. The company reported consolidated revenue of $345.1 million, an increase from $307.2 million in the same quarter of the previous year. Net income for the quarter was $12.9 million, a notable improvement compared to a net loss of $31.0 million in the fourth quarter of fiscal year 2024. Adjusted EBITDA for the quarter was $2.7 million, down from $14.4 million in the prior year quarter. For fiscal year 2026, SelectQuote has provided guidance, expecting revenue to range between $1.650 billion and $1.750 billion. The company also anticipates Adjusted EBITDA to be in the range of $120 million to $150 million. Breaking down the segment results for the fourth quarter of fiscal year 2025, the Senior segment reported revenue of $82.5 million with an Adjusted EBITDA of $7.7 million. The Healthcare Services segment generated $214.0 million in revenue and an Adjusted EBITDA of $11.9 million. The Life segment had revenue of $48.0 million and an Adjusted EBITDA of $6.9 million. SelectQuote continues to emphasize the strength of its holistic healthcare services model, attributing its performance to the talent and hard work of its leadership and workforce.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SelectQuote Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250821115007) on August 21, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10